US FDA's Expedited Access Pathway: 17 Medical Devices And Counting
This article was originally published in SRA
Executive Summary
Some 17 medical devices have been granted designation under the US Food and Drug Administration's year-old expedited access pathway (EAP) for helping to fast track innovative devices to market1.
You may also be interested in...
Medical Device Regulations In Latin America And The Way Forward
Akhila Krishnan reviews the different regulatory requirements for medical devices in five Latin American countries and discusses how harmonization initiatives will make things easier for manufacturers in this guest column.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.